EAPC Premium Access

Discussion : Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Interactions and management.

Congress Session

3 more presentations in this session

What is NAFLD/NASH? .

Speaker: Doctor H. Cortez-Pinto (Lisbon, PT)

Thumbnail

NAFLD/NASH and the heart.

Speaker: Doctor M. Tushuizen (Leiden, NL)

Thumbnail

Managing patients with cardiovascular disease and NAFLD/NASH.

Speaker: Professor S. Francque (Antwerpen, BE)

Thumbnail

Access the full session

Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Interactions and management

Speakers: Doctor H. Cortez-Pinto, Doctor M. Tushuizen, Professor S. Francque
Thumbnail

About the event

Image

ESC Preventive Cardiology 2022

7 April - 9 April 2022

Sessions Presentations

Related content

ACVC Premium Access

Cardiogenic shock: state of the art 2022 - discussion.

19 March 2022

ACVC Premium Access

Pharmacological treatment: how to choose your drug (if any)

19 March 2022

ACVC Premium Access

Pathophysiology and evolving definition of cardiogenic shock.

19 March 2022

This platform is supported by

logo Novo Nordisk